These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 10395379

  • 1. Liposomal encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats.
    Engelmann C, Panis Y, Bolard J, Diquet B, Fabre M, Nagy H, Soubrane O, Houssin D, Klatzmann D.
    Hum Gene Ther; 1999 Jun 10; 10(9):1545-51. PubMed ID: 10395379
    [Abstract] [Full Text] [Related]

  • 2. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E, Kawano K, Hattori Y, Fukushima M, Hayashi K, Maitani Y.
    J Control Release; 2007 Jul 16; 120(1-2):104-10. PubMed ID: 17509714
    [Abstract] [Full Text] [Related]

  • 3. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR, Kittaka M, Gordon EM, Gray B, Stins MF, McComb JG, Jovanovic S, Tabrizi P, Weiss MH, Bartus R, Anderson WF, Zlokovic BV.
    Hum Gene Ther; 1998 May 01; 9(7):989-95. PubMed ID: 9607410
    [Abstract] [Full Text] [Related]

  • 4. Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cells.
    Pasanen T, Karppinen A, Alhonen L, Jänne J, Wahlfors J.
    Int J Cancer; 2003 Apr 10; 104(3):380-8. PubMed ID: 12569563
    [Abstract] [Full Text] [Related]

  • 5. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y, Xu CJ, Liu XS, Wu CQ, Zhong CP, Gu JR.
    Ai Zheng; 2005 Aug 10; 24(8):909-14. PubMed ID: 16086864
    [Abstract] [Full Text] [Related]

  • 6. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Aug 10; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 7. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F, Moriuchi S, Maeda M, Sano A, Maruno M, Tsanaclis AM, Marino R, Glorioso JC, Yoshimine T.
    Gene Ther; 2002 Dec 10; 9(24):1653-8. PubMed ID: 12457278
    [Abstract] [Full Text] [Related]

  • 8. Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.
    Kramm CM, Rainov NG, Sena-Esteves M, Barnett FH, Chase M, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO.
    Hum Gene Ther; 1996 Oct 20; 7(16):1989-94. PubMed ID: 8930659
    [Abstract] [Full Text] [Related]

  • 9. Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells.
    Balzarini J, Degrève B, Andrei G, Neyts J, Sandvold M, Myhren F, de Clercq E.
    Gene Ther; 1998 Mar 20; 5(3):419-26. PubMed ID: 9614564
    [Abstract] [Full Text] [Related]

  • 10. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE, Yu HM, Liu RS, Lin M, Gelovani JG, Hwang JJ, Wei HJ, Deng WP.
    J Nucl Med; 2006 Jul 20; 47(7):1161-71. PubMed ID: 16818951
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
    Eastham JA, Chen SH, Sehgal I, Yang G, Timme TL, Hall SJ, Woo SL, Thompson TC.
    Hum Gene Ther; 1996 Mar 01; 7(4):515-23. PubMed ID: 8800746
    [Abstract] [Full Text] [Related]

  • 12. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA, Lamb C, Hogan S, Smiley WR, Kleinschmidt-Demasters BK, Burrows FJ.
    Cancer Gene Ther; 2000 Jan 01; 7(1):118-27. PubMed ID: 10678364
    [Abstract] [Full Text] [Related]

  • 13. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q, Zhang D, Wan M, Jin L.
    Cancer Biother Radiopharm; 2007 Dec 01; 22(6):755-61. PubMed ID: 18158766
    [Abstract] [Full Text] [Related]

  • 14. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD, Boenicke L, Schniewind B, Henne-Bruns D, Kalthoff H.
    Cancer Gene Ther; 2000 Jun 01; 7(6):927-38. PubMed ID: 10880025
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y, Gilbert JD, Kim JH, Freytag SO.
    Clin Cancer Res; 1999 Dec 01; 5(12):4224-32. PubMed ID: 10632364
    [Abstract] [Full Text] [Related]

  • 16. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
    Liu CS, Kong B, Xia HH, Ellem KA, Wei MQ.
    J Gene Med; 2001 Dec 01; 3(2):145-52. PubMed ID: 11318113
    [Abstract] [Full Text] [Related]

  • 17. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y, Lu G, Xiao Y, Zeng F, Zhang Q, Xiong P, Feng W.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1484-7. PubMed ID: 12509912
    [Abstract] [Full Text] [Related]

  • 18. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y, Ohtsuru A, Kaneda Y, Nagayama Y, Kawazoe Y, Eguchi S, Kuroda H, Fujioka H, Ito M, Kanematsu T, Yamashita S.
    Hum Gene Ther; 1999 Jun 10; 10(9):1509-19. PubMed ID: 10395376
    [Abstract] [Full Text] [Related]

  • 19. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.
    Cancer Gene Ther; 2003 May 10; 10(5):353-64. PubMed ID: 12719705
    [Abstract] [Full Text] [Related]

  • 20. Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion.
    Herraiz M, Beraza N, Solano A, Sangro B, Montoya J, Qian C, Prieto J, Bustos M.
    Hum Gene Ther; 2003 Mar 20; 14(5):463-72. PubMed ID: 12691611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.